Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Nov 14;15(2):69-75.
doi: 10.1007/s12522-015-0224-6. eCollection 2016 Apr.

Preimplantation genetic diagnosis: an update on current technologies and ethical considerations

Kou Sueoka  1
Affiliations
Review

Preimplantation genetic diagnosis: an update on current technologies and ethical considerations

Kou Sueoka. Reprod Med Biol. .

Abstract

The aim of reproductive medicine is to support the birth of healthy children. Advances in assisted reproductive technologies and genetic analysis have led to the introduction of preimplantation genetic diagnosis (PGD) for embryos. Indications for PGD have been a major topic in the fields of ethics and law. Concerns vary by nation, religion, population, and segment, and the continued rapid development of new technologies. In contrast to the ethical augment, technology has been developing at an excessively rapid speed. The most significant recent technological development provides the ability to perform whole genome amplification and sequencing of single embryonic cells by microarray or next-generation sequencing methods. As new affordable technologies are introduced, patients are presented with a growing variety of PGD options. Simultaneously, the ethical guidelines for the indications for testing and handling of genetic information must also rapidly correspond to the changes.

Keywords: Microarray; Polymerase chain reaction (PCR); Preimplantation genetic diagnosis (PGD); Preimplantation genetic screening (PGS); Whole genome amplification.

PubMed Disclaimer

Conflict of interest statement

Kou Sueoka declares that he has no conflict of interest.

References

    1. Handyside AH, Kontogianni EH, Hardy K, Winston RM. Pregnancies from biopsied human preimplantation embryos sexed by Y‐specific DNA amplification. Nature, 1990, 344, 768–770 - DOI - PubMed
    1. Harper JC, SenGupta SB. Preimplantation genetic diagnosis: State of the ART 2011. Hum Genet, 2012, 131, 175–186 - DOI - PubMed
    1. Verlinsky Y, Cieslak J, Freidine M, Ivakhnenko V, Wolf G, Kovalinskaya L et al. Pregnancies following preconception diagnosis of common aneuploidies by fluorescent in situ hybridization. Hum Reprod, 1995, 10, 1923–1927 - PubMed
    1. Staessen C, Platteau P, Assche E, Michiels A, Tourmaye H, Camus M et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod, 2004, 19, 2849–2858 - DOI - PubMed
    1. Stevens J, Wale P, Surrey ES, Schoolcraft WB. Is aneuploidy screening for patients aged 35 or over beneficial? A prospective randomized trial. Fertil Steril., 2004, 82, 249 - DOI